Vaccinex, Inc. (VCNX)
OTCMKTS · Delayed Price · Currency is USD
1.370
+0.210 (18.10%)
Jan 30, 2026, 9:30 AM EST
Vaccinex Market Cap
Vaccinex has a market cap or net worth of $3.67 million as of February 2, 2026. Its market cap has decreased by -57.68% in one year.
Market Cap
3.67M
Enterprise Value
4.25M
Revenue
601.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.37
Market Cap Chart
Since August 9, 2018, Vaccinex's market cap has decreased from 130.58M to 3.67M, a decrease of -97.19%. That is a compound annual growth rate of -37.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 3.67M | 27.38% |
| Dec 31, 2025 | 2.88M | 9.74% |
| Dec 31, 2024 | 2.62M | -68.42% |
| Dec 29, 2023 | 8.31M | -74.16% |
| Dec 30, 2022 | 32.15M | 0.35% |
| Dec 31, 2021 | 32.03M | -30.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 9, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Enzon Pharmaceuticals | 5.86M |
| BetterLife Pharma | 5.77M |
| AXIM Biotechnologies | 5.19M |
| Nymox Pharmaceutical | 4.69M |
| Bioxytran | 4.61M |
| Mosaic ImmunoEngineering | 4.16M |
| ProtoKinetix | 4.04M |
| Clearside Biomedical | 3.93M |